Key result
The SK-channel-inhibitor AP14145 prevented INAP-associated AERP-shortening and AF-susceptibility in a porcine model of obstructive respiratory events without impairing ventricular electrophysiology.
Why the study?
Does the SK-channel inhibitor AP14145 prevent atrial arrhythmogenic changes in a porcine model for obstructive respiratory events?
Does the SK-channel inhibitor AP14145 prevent atrial arrhythmogenic changes in a porcine model for obstructive respiratory events?
SK-channel inhibition with AP14145 prevents atrial arrhythmogenic changes in a porcine model of obstructive sleep apnea without adverse ventricular electrophysiological effects.
May offer atrial-selective AF protection in OSA models; hypothesis-generating for human translation.
BACKGROUND: (SK)-channel inhibition in a porcine model for obstructive respiratory events. METHODS: In spontaneously breathing pigs, obstructive respiratory events were simulated by intermittent negative upper airway pressure (INAP) applied via a pressure device connected to the intubation tube. INAP was applied for 75 s, every 10 min, three times before and three times during infusion of the SK-channel inhibitor AP14145. Atrial effective refractory periods (AERP) were acquired before (pre-INAP), during (INAP) and after (post-) INAP. AF-inducibility was determined by a S1S2 atrial pacing protocol. Ventricular arrhythmicity was evaluated by heart rate adjusted QT-interval duration (QT-paced) and electromechanical window (EMW) shortening. RESULTS: During vehicle infusion, INAP transiently shortened AERP (pre-INAP: 135 ± 10 ms vs. post-INAP 101 ± 11 ms; p = .008) and increased AF-inducibility. QT-paced prolonged during INAP (pre-INAP 270 ± 7 ms vs. INAP 275 ± 7 ms; p = .04) and EMW shortened progressively throughout INAP and post-INAP (pre-INAP 80 ± 4 ms; INAP 59 ± 6 ms, post-INAP 46 ± 10 ms). AP14145 prolonged baseline AERP, partially prevented INAP-induced AERP-shortening and reduced AF-susceptibility. AP14145 did not alter QT-paced at baseline (pre-AP14145 270 ± 7 ms vs. AP14145 268 ± 6 ms, p = .83) or QT-paced and EMW-shortening during INAP. CONCLUSION: In a pig model for obstructive respiratory events, the SK-channel-inhibitor AP14145 prevented INAP-associated AERP-shortening and AF-susceptibility without impairing ventricular electrophysiology. Whether SK-channels represent a target for OSA-related AF in humans warrants further study.
No takes yet. Share an insight, caveat, or question.
Linz et al. (2022) studied Obstructive respiratory events and atrial fibrillation susceptibility. AP14145 (SK-channel inhibitor) vs. Vehicle infusion / pre-infusion baseline was evaluated on Atrial effective refractory periods (AERP) and AF-inducibility. The SK-channel-inhibitor AP14145 prevented INAP-associated AERP-shortening and AF-susceptibility in a porcine model of obstructive respiratory events without impairing ventricular electrophysiology.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: